Please login to the form below

Not currently logged in


This page shows the latest acquisitions news and features for those working in and with pharma, biotech and healthcare.

Merck & Co halts development of potential COVID-19 drug MK-7110

Merck & Co halts development of potential COVID-19 drug MK-7110

The company acquired MK-7110, a recombinant fusion protein, as part of its acquisition of OncoImmune in December 2020. ... Following the acquisition, the US Food and Drug Administration (FDA) told Merck &Co that additional data, as well as a study

Latest news

More from news
Approximately 198 fully matching, plus 1,247 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 75 fully matching, plus 95 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 120 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 10 fully matching, plus 88 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...